Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Dec:28:10760296221091213.
doi: 10.1177/10760296221091213.

Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients

Indalecio Carboni Bisso  1 , Iván Huespe  1   2   3 , Eduardo Prado  1 , Melina Garbarini  1 , Marina Sol López  4   5 , Luis Barrera  4   5 , Marcos Las Heras  1 , Jorge Sinner  1   5 , Marta Martinuzzo  4   5
Affiliations

Rotational Thromboelastometry Profile among Critically ill COVID-19 Patients

Indalecio Carboni Bisso et al. Clin Appl Thromb Hemost. 2022 Jan-Dec.
No abstract available

Keywords: COVID-19; SARS-coV-2; artificial; critical care; respiration; thromboelastometry.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Evolution of medians of different parameters: D-Dimer and fibrinogen, as well as NaHEPTEM temograms parameters CFT, MaxV, A5 and MCF, during the evaluation period (T1, T5 and T10) according to mechanical ventilation treatment or not. Green lines indicated the parameter median obtained in the healthy control group.
Figure 2.
Figure 2.
Distribution of hemostatic parameters: D-Dimer (a) and fibrinogen (b), as well as NaHEPTEM parameters CFT(c), MaxV(d), A5(e) and MCF (f) in all blood samples performed from ICU patients with COVID-19, according to the need of mechanical ventilation treatment. Dashed lines indicated the parameter median obtained in the healthy control group.
See this image and copyright information in PMC

References

    1. Gu SX, Tyagi T, Jain K, et al.. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. Epub ahead of print 19 November 2020. doi: 10.1038/s41569-020-00469-1. - DOI - PMC - PubMed
    1. Ranucci M, Ballotta A, Di Dedda U, et al.. The procoagulant pattern of patients with COVID–19 acute respiratory distress syndrome. J Thromb Haemostasis. 2020;18:1747–1751. doi:10.1111/jth.14854 - DOI - PMC - PubMed
    1. Panigada M, Bottino N, Tagliabue P, et al.. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020;18:1738–1742. doi:10.1111/jth.14850 - DOI - PMC - PubMed
    1. Spiezia L, Boscolo A, Poletto F, et al.. COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 2020;120:998–1000. doi:10.1055/s-0040-1714350 - DOI - PMC - PubMed
    1. Pavoni V, Gianesello L, Pazzi M, et al.. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis 2020;50:281–286. doi:10.1007/s11239-020-02130-7 - DOI - PMC - PubMed